Collaboration - January 30, 2017
Novo Nordisk and Glooko partner
Novo Nordisk and Glooko announces that the two companies will work together to deliver jointly-developed and branded digital health solutions for people with diabetes. The non-exclusive collaboration will combine Novo Nordisk’s knowledge of diabetes with Glooko’s digital platform and data analytics expertise. Building on Glooko’s mobile and web platforms, the companies aim to deliver personalised, […]
Collaboration - January 25, 2017
Nuevolution in scientific article with Nobel Laureate
Nuevolution announces the publication of the scientific article entitled “An allosteric “Beta-Blocker” isolated from a DNA-encoded small molecule library” in the Proceedings of the National Academy of Sciences, USA. The article presents work from the ongoing collaboration between Nuevolution and the group of Nobel Laureate Dr. Robert J. Lefkowitz at Duke University involving the screening […]
Biotech Business - January 18, 2017
Pelago Bioscience and CBCS collaborates
Pelago Bioscience and Chemical Biology Consortium Sweden (CBCS), the chemical biology facility at Karolinska Institutet and SciLifeLab (Science for Life Laboratory) will collaborate to develop high throughput automated CETSA-based Target Engagement Assays for multiple targets. The collaboration is based on expanding Pelago’s CETSA technology capabilities and will enable screening of large chemical libraries for identification […]
Collaboration - January 16, 2017
OssDsign announces new European partnership for commercialization
Karolinska Development announces that portfolio company OssDsign AB, a Swedish designer, manufacturer and distributor of next generation implants for cranial and facial reconstruction, has entered new commercial partnerships covering distribution of its products in Italy, Spain, Switzerland, Austria and The Netherlands. OssDsign’s lead products – OSSDSIGN Cranial and OSSDSIGN Facial – are already on sale […]
Biotech Business - January 13, 2017
Pelago collaborates with Sygnature
UK’s Sygnature Discovery will collaborate with Swedish biotech company Pelago Bioscience to provide target engagement assays with Pelago’s patented Cellular Thermal Shift Assay (CETSA) method. Pelago’s CETSA method enables measurements to be made within cellular systems. For the first time researchers can now measure directly how a compound interacts with its target within the cell […]
Collaboration - January 2, 2017
Global partnership for multiple sclerosis launched
A global partnership called ‘MultipleMS’, coordinated by Karolinska Institute, has been awarded 15 million euro from the European Commission in the Horizon2020 program to find novel and better treatments for Multiple Sclerosis (MS). In this project, universities and companies across 12 European countries and the US will unite efforts to tailor the development and application […]
